Publications
-
Bermudo G, Del Rio B, Vicens-Zygmunt V, Bordas-Martinez J, Hernández M, Valenzuela C, Laporta R, Rigual Bobillo J, Portillo K, Millán-Billi P, Balcells E, Badenes-Bonet D, Bolivar S, Rodríguez-Portal JA, López Ramirez C, Tomás L, Fernández de Roitegi K, Sellarés J, Castillo D, González J, Barril S, Gutiérrez-Rodríguez Y, Caballero P, Alarcon J, Peñafiel J, Sanz-Santos J, Blavia R, Cristina Caupena Auledas, Segovia P, Santos-Pérez S, Ferrer A, Badia MB, Hereu P, Fuentes M, Montes-Worboys A, Franquet T, Luburich P and Molina-Molina M.
Pirfenidone in post-COVID19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomized clinical trial.
EUROPEAN RESPIRATORY JOURNAL . 65(4): .
-
Brunet-Mas E, Selva A, Bas-Cutrina F, Brujats A, Caballol B, Font R, Gomez B, Gonzalez-Muñosa C, Busquets D, Monfort D, Vera DP, Maristany E, Cirera G, Torres G, Castro-Poceiro J, Lopez J, Gonzalez-Gonzalez L, Màrquez-Mosquera L, Gallach M, Esteve M, Tremosa G, Sandra Torra Alzina, Robles-Alonso V, Garcia-Iglesias P, Rodríguez-Lago I and Calvet X.
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY . 16(2): .